About Dompé
Dompé farmaceutici is an international biopharmaceutical company involved in all activities of the pharmaceutical value chain, from research to development, production and marketing. As a long-established family company, we blend the stability that comes from our 130-year heritage with the agility and dynamism of a start-up.
We can turn transformative breakthroughs into treatments because we have the right qualities and capabilities to deliver new drugs. Our 160,000 square meter R&D and production site in L’Aquila, Italy, is the heart of Dompé. Here, we conduct vital research, and produce and distribute our primary care and biotech products.
Primary Care includes a broad spectrum of over-the-counter treatment solutions, prescription medications, supplements and medical devices. Our Biotech focuses on the development of treatments for rare diseases. The main therapeutic areas include pain relief, inflammation, ophthalmology, diabetes care, nutrition and oncology.
In the pursuit of improving human health, our R&D strives to break through in unconventional places. This is what led us to Nerve Growth Factor (NGF), a Nobel Prize-winning discovery made in 1986. We leveraged 50 years of research to transform this discovery into a breakthrough treatment. Our human recombinant NGF, cenegermin, is the first treatment for a rare degenerative eye disease, neurotrophic keratitis. That deep appreciation of science keeps us committed to investigating neurotrophins.
Our relentless pursuit in identifying new treatments for diseases allowed us to harness the potential of bioinformatics to accelerate the drug discovery process. The result is Exscalate, a structure-based virtual screening platform developed in-house and currently one of the most powerful supercomputing and artificial intelligence platforms for drug testing.
We are focused on the road ahead. Our hunger to deliver what patients need from science keeps us focused on what matters.
We embrace the challenge in science.
|
|
|
501-1,000 employees
View all Dompé employees
|
|
Pharmaceuticals
|
|
$100M–$500M
|
|
+39 02 66 80 81
|
|
Via Santa Lucia, Milano, Lombardia 20122, IT
|
|
None
|
|
Biotechnology, Research And Development, Pharmaceuticals, Innovation, Primary Care, Self-Medication Products
|
Dompé Alternatives
Frequently Asked Questions about Dompé
Massimo Radaelli is the CEO of Dompé. To contact Massimo Radaelli email at [email protected].
Dompé headquarters is located at Via Santa Lucia, Milano, Lombardia 20122, IT.
Dompé generates an estimated $100M–$500M annually, based on industry analysis and publicly available market data.
You can contact Dompé by calling +39 02 66 80 81.
Dompé Staff Directory
Search Dompé Staff Directory
Find accurate personal emails, work emails and phone numbers for employees
Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut
Find countless prospects outside of LinkedIn fast
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.
